Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

100.40
BATS BZX Real-Time Price
As of 9:39am ET
 +2.07 / +2.11%
Today’s Change
97.52
Today|||52-Week Range
181.03
-35.89%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close98.33
Today’s open100.00
Day’s range100.00 - 100.93
Volume628
Average volume (3 months)735,695
Market cap$4.4B
Dividend yield--
Data as of 9:39am ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+8.87%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+13.76%
P/E ratio5.6
Price/Sales5.47
Price/Book2.83

Competitors

----
OPKOPKO Health Inc+0.25+2.83%
GRFSGrifols SA+0.61+4.07%
SGENSeattle Genetics Inc+1.13+3.11%
Data as of 9:39am ET, 06/28/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.10
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers

Search for Jobs